Sexually dimorphic effects of ADNP mutation and Davunotide treatment on mice hippocampal transcriptome

ABSTRACT: ADNP haplo-insufficient (Adnp +/- ) mice or CRSIPR/Cas9 edited to carry the most prevalent neurodevelopmental ADNP syndrome mutation, p.Tyr718*. A subgroup was treated the ADNP fragment, investigational drug, NAP (davunetide).

ORGANISM(S): Mus musculus

PROVIDER: GSE272331 | GEO | 2025/05/30

REPOSITORIES: GEO